Prescient Therapeutics AGM 2024
Prescient Therapeutics AGM 2024 Register to stay up to date with Prescient Therapeutics Featured Speakers...
Prescient Therapeutics AGM 2024 Register to stay up to date with Prescient Therapeutics Featured Speakers...
Prescient Therapeutics: PTX-100 targeted cell therapy briefing Prescient Therapeutics CEO and MD Steven Yatomi-Clarke gave...
Prescient was pleased to present data on our cell therapies at the prestigious International Society...
Prescient Therapeutics: Cell Therapies presentations from ISCT Prescient Therapeutics held a special Cell Therapies briefing...
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke presented at the...
Prescient Therapeutics Shareholder Briefing In this session, Prescient Therapeutics CEO and MD Steven Yatomi-Clarke discussed:...
Prescient Therapeutics: PTX-100 targeted cell therapy briefing Prescient Therapeutics CEO and MD Steven Yatomi-Clarke gave...
Clinical stage oncology company, Prescient Therapeutics, has a diverse stable of emerging and later stage...
Prescient Therapeutics Shareholder Briefing In this session, Prescient Therapeutics CEO and MD Steven Yatomi-Clarke discussed:...
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke presented at the...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.